AstraZeneca’s vaccine useful despite new variants, says WHO
The shot still appears to prevent more serious problems, says expert, despite poor numbers in local trials against the SA variant
09 February 2021 - 15:03
Zurich/Johannesburg — AstraZeneca’s Covid-19 vaccine is worth using in areas hit by mutated strains of the virus, World Health Organization (WHO) officials and partners have said, countering concerns about reduced effectiveness that arose in a recent test.
There’s evidence the vaccine AstraZeneca developed with the University of Oxford could provide meaningful protection against severe disease caused by the highly infectious variant that emerged in SA, called B.1.351, according to Kate O’Brien, who heads the WHO’s vaccination division. The global health agency is preparing to decide on an emergency-use listing for AstraZeneca-Oxford shots made in India and South Korea...
BL Premium
This article is reserved for our subscribers.
A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.
Already subscribed? Simply sign in below.
Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now